OCLASSEN PHARMACEUTICALS

Oclassen Pharmaceuticals, Inc. was acquired by Watson Pharmaceuticals Inc.

#More

OCLASSEN PHARMACEUTICALS

Industry:
Biotechnology Health Care

Status:
Active


More informations about "Oclassen Pharmaceuticals"

Oclassen Pharmaceuticals - Crunchbase Company Profile & Funding

Organization. Oclassen Pharmaceuticals . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. ... Who are Oclassen Pharmaceuticals 's competitors? Alternatives โ€ฆSee details»

Oclassen Pharmaceuticals - PitchBook

Oclassen Pharmaceuticals General Information Description. Developer of therapeutics in the fields of dermatology and sexually transmitted diseases. The company offers dermatology โ€ฆSee details»

Oclassen Pharmaceuticals - Products, Competitors, Financials, โ€ฆ

Oclassen Pharmaceuticals was founded in 1985. Where is Oclassen Pharmaceuticals's headquarters? Oclassen Pharmaceuticals's headquarters is located at 100 Pelican Way, San โ€ฆSee details»

Oclassen Pharmaceuticals Inc - Company Profile and News

Oclassen Pharmaceuticals, Inc. develops and markets specialty prescription pharmaceuticals for the treatment of infectious and skin diseases, with an initial focus on dermatology and urology. โ€ฆSee details»

OCLASSEN PHARMACEUTICALS, INC. :: California (US)

Apr 21, 1993 Free and open company data on California (US) company OCLASSEN PHARMACEUTICALS, INC. (company number 1522728), 100 PELICAN WAY SAN RAFAEL โ€ฆSee details»

Oclassen Pharmaceuticals - Drug pipelines, Patents, Clinical trials ...

Explore Oclassen Pharmaceuticals with its drug pipeline, therapeutic area, technology platform, 2 clinical trials.See details»

OCLASSEN PHARMACEUTICALS, INC. - 1522728 - California

OCLASSEN PHARMACEUTICALS, INC. American (California) company, Company number: 1522728, Incorporation Date Mar 17, 1992;, Address: 100 PELICAN WAY SAN RAFAEL CA โ€ฆSee details»

Oclassen Pharmaceuticals, Inc.: Drug pipelines, Patents, Clinical ...

Explore Oclassen Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»

Oclassen Pharmaceuticals Overview - Salary.com

Discover essential details about Oclassen Pharmaceuticals, including address, contact, and journey of our company's evolution. Discover essential details about Oclassen โ€ฆSee details»

Oclassen Pharmaceuticals, Inc.:Company Profile & Technical โ€ฆ

Oclassen Pharmaceuticals, Inc. is a company that provides Dermatology, Botanical drug, Herb and more. Oclassen Pharmaceuticals, Inc. is headquartered in United States California. โ€ฆSee details»

Oclassen Pharmaceuticals - insights.citeline.com

FIAC, which can be administered both orally and intravenously, will initially be developed for cytomegalovirus infections in AIDS patients. FIAU has already been studied in about 100 โ€ฆSee details»

Glenn Oclassen, President and CEO, Transcept Pharmaceuticals Inc.

Mar 16, 2009 Oclassen started in sales, moved to running the dermatology division of Allergan and in the mid-1980s launched Oclassen Pharmaceuticals. That was bought in 1997 by โ€ฆSee details»

Oclassen Pharmaceuticals, Inc.:Funding,Funding Rounds,Funding โ€ฆ

Discovery Company profile page for Oclassen Pharmaceuticals, Inc. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»

Oclassen Pharmaceuticals - Overview, Competitors, and โ€ฆ

Reach Oclassen Pharmaceuticalsโ€˜s employees by department, seniority, title, and much more. This website uses cookies. Our website utilizes cookies for the customization of content and โ€ฆSee details»

Oclassen Pharmaceuticals - CB Insights

Explore {Oclassen Pharmaceuticals's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Oclassen โ€ฆSee details»

Oclassen Pharmaceuticals Stock Price, Funding, Valuation, Revenue ...

Feb 27, 1997 See Oclassen Pharmaceuticals funding rounds, investors, investments, exits and more. Evaluate their financials based on Oclassen Pharmaceuticals's post-money valuation โ€ฆSee details»

Verrica Pharmaceuticals Announces Passing of Board of Directors โ€ฆ

Nov 19, 2019 Prior, he founded Oclassen Pharmaceuticals, which was sold to Watson Laboratories in 1997. About Verrica Pharmaceuticals Inc. Verrica is a medical dermatology โ€ฆSee details»

Oclassen Pharmaceuticals, Inc.:Patent,Patent Application,Portfolio ...

Discovery Company profile page for Oclassen Pharmaceuticals, Inc. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»

Patents Assigned to Oclassen Pharmaceuticals, Inc ... - Justia โ€ฆ

Dec 23, 1992 Patents Assigned to Oclassen Pharmaceuticals, Inc. Methods for treatment with compositions effective against acyclovir-resistant strains of herpes viruses. Patent number: โ€ฆSee details»

OCLASSEN REVIVES IPO - | BioWorld

Jan 13, 1993 Oclassen Pharmaceuticals Inc. announced Tuesday that it hasfiled an amended registration statement with the Securitiesand Exchange Commission for an initial public โ€ฆSee details»